Access cutting-edge eosinophilic asthma treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access eosinophilic asthma specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related eosinophilic asthma treatment provided free
This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated with medium-dose ICS-LABA compared to the conventional treatment step of escalation of inhaled therapy to high-dose ICS-LABA.
Sponsor: AstraZeneca
Check if you qualify for this eosinophilic asthma clinical trial in Tucson, AZ
If you're searching for eosinophilic asthma treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced eosinophilic asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.